Listen below to two ‘titans’ of engineered T cell therapy to appreciate why cancer-specific T cell receptor targets for solid tumors represent some of the most coveted “victories” in cancer immunotherapy.

Media Coverage

 

Setting the Bodies Serial Killers Lose on Cancer

Andrew Pollack, August 1, 2016, NYTimes

"After a long, intense pursuit, researchers are close to

bringing to market a daring new treatment: cell therapy

that turbocharges the immune system to fight cancer".

http://www.nytimes.com/2016/08/02/health/cancer-cell-therapy-immune-system.html?_r=0

 

 

Overview of Cancer Immunotherapy

 

Catapult UK Whitepapers

Genetically Modified T Cell Therapies for Cancer – Basic Facts

https://ct.catapult.org.uk/documents/10588/12014/pdf/2b2c5b13-5ddc-441d-8ce6-0581b8ee731f

T cell therapies V.2

https://ct.catapult.org.uk/documents/10588/11999/pdf/4a647cc7-e4c1-4299-8b9d-9c445b1a5e10

 

Cancer Resarch Institute

What is cancer immunotherapy?

http://www.cancerresearch.org/cancer-immunotherapy

 

National Cancer Institute

CAR T-Cell Therapy: Engineering Patients’ Immune Cells to Treat Their Cancers

http://www.cancer.gov/cancertopics/research-updates/2013/CAR-T-Cells

 

 

US Cancer Statistics

National Cancer Institute

http://seer.cancer.gov/statistics/summaries.html

American Cancer Society

http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/

 

 

Professional Organizations

Society for Immunotherapy of Cancer

http://www.sitcancer.org

American Society for Cell and Gene Therapy

http://www.asgct.org

Association for Cancer Immunotherapy

http://www.cimt.eu/home

 

 

 

 

© 2017 Verik Bio, Inc
website design by Alice Sargent